Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells
ABSTRACT Background Methylthioadenosine phosphorylase (MTAP) and protein arginine methyltransferase 5 (PRMT5) are considered to be a synthetic lethal pair of targets, due to the fact that deletion of MTAP leads to massive production of methylthioadenosine (MTA) decreasing the activity of PRMT5. In v...
Saved in:
| Main Authors: | Yunjie Wang, Xiaohui Sun, Runchen Ma, Xiaofan Zhang, Shengmin Ji, Zhaofeng Liu, Gangqiang Yang, Hongbo Wang, Peng Zhang, Jianzhao Zhang, Jingwei Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70526 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
by: Kimberly J. Briggs, et al.
Published: (2025-02-01) -
A systematic literature review of MTAP deletions in solid and hematologic Cancers
by: Mary C. Clouser, et al.
Published: (2025-01-01) -
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer
by: Natalia Gorbokon, et al.
Published: (2025-01-01) -
MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
by: Natalia Gorbokon, et al.
Published: (2025-07-01) -
Prognostic role of high MTAP expression is reversed by the ERG status in prostate cancer treated by radical prostatectomy
by: Natalia Gorbokon, et al.
Published: (2025-09-01)